You have 9 free searches left this month | for more free features.

Changzhou (1)

Nanjing (1)

Suzhou (1)

Wuxi (1)

Yangzhou (1)

Advanced Colorectal Cancer (1)

Recruiting (1)

phase 1/phase 2 (1)

Jiangsu Cancer Institute & Hospital (1)

surufatinib,camrelizumab,irinotecan,gm-csf (1)

drug (1)

Other (1)

Interventional (1)

surufatinib,camrelizumab,irinotecan,gm-csf

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jun 11, 2021